4Rafael Morales-Barrera,Joaquim Bellmunt,Cristina Suárez,Claudia Valverde,Marta Guix,Cesar Serrano,Manuel Gallén,Joan Carles.Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function[J].European Journal of Cancer.2012(12)
6ERIC WINQUIST,TRICIA S. KIRCHNER,ROANNE SEGAL,JOSEPH CHIN,HIMU LUKKA.Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis[J].The Journal of Urology.2004(2)
7Luc George,Franck Bladou,Valérie Jeanne Bardou,Gwenaelle Gravis,Agnes Tallet,Claude Alzieu,Gérard Serment,Naji Salem.Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy[J].Urology.2004(3)
8William U. Shipley,Anthony L. Zietman,Donald S. Kaufman,John J. Coen,Howard M. Sandler.Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates—The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences[J].Seminars in Radiation Oncology.2004(1)
9F. de la ROSA,R. GARCIA-CARBONERO,J. PASSAS,A. ROSINO,P. LIANES,L. PAZ-ARES.Primary Cisplatin, Methotrexate and Vinblastine Chemotherapy With Selective Bladder Preservation for Muscle Invasive Carcinoma of the Bladder: Long-Term Followup of a Prospective Study[J].The Journal of Urology.2002(6)
